GlassScriptPhysician profile
Ariel Ikesakes
NPI 1215559406
$545.36
in general payments reported to CMS, 2019-2025
12 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.29 · 2023: $15.64 · 2024: $275 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $147.74 | 2024-2025 | Krystexxa |
| Sanofi Pasteur INC. | $67.33 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $58.28 | 2024 | Vaxelis, Gardasil, Vaxneuvance |
| Pfizer INC. | $57.35 | 2023-2025 | |
| Glaxosmithkline, LLC. | $55.98 | 2024-2025 | Shingrix, Bexsero, Flulaval Quadrivalent |
| Dexcom, INC. | $27.32 | 2024 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $25.47 | 2025 | Aptima |
| Organon LLC | $23.94 | 2022 | |
| Alkermes, INC. | $22.53 | 2025 | Vivitrol |
| Abbvie INC. | $21.80 | 2024 | |
| Abbott Laboratories | $20.60 | 2025 | Eterna |
| Novo Nordisk INC | $17.02 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Ikesakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.